Press release
Key Trend Reshaping the Kesimpta Market in 2025: Kesimpta's Impact On Relapsing Multiple Sclerosis (RMS)
Kesimpta Market Share
The anticipated growth of the kesimpta market can be linked to the escalating prevalence of multiple sclerosis (MS). MS, a chronic autoimmune disease, impairs the central nervous system, causing symptoms like muscle weakness, vision issues, and cognitive dysfunction, leading to nerve fiber degeneration. This surge in MS cases is likely due to factors like enhanced diagnostics, increased awareness, and improved reporting mechanisms. Kesimpta is administered to manage relapsing forms of MS by targeting B-cells, thereby reducing relapses and slowing the progression of disability. For example, according to Public Health Scotland's data from July 2023, the percentage of newly diagnosed MS patients rose to 87.2% in 2022 from 85.7%, with 491 new cases bringing the total to 6,359. As a result, the rise in multiple sclerosis cases continues to fuel the kesimpta market's expansion.
Get Your Kesimpta Market Report Here:
https://www.thebusinessresearchcompany.com/report/kesimpta-global-market-report
What growth opportunities are expected to drive the kesimpta market's CAGR through 2034?
In recent times, the Kesimpta market has experienced a XX (HCAGR) surge. The market is projected to escalate from a valuation of $XX million in 2024 to $XX million in 2025, reflecting a compound annual growth rate (CAGR) of XX%. This significant progression during the historical period can be ascribed to a number of factors including the broadening of healthcare accessibility, the emergence of sophisticated biological therapies, an escalating occurrence of multiple sclerosis, the sanction of Kesimpta by regulation bodies, and a better understanding and awareness about multiple sclerosis.
In the coming years, the market size for Kesimpta is projected to experience a XX (FCAGR) growth. By 2029, the market is forecasted to reach a value of $XX million, with a XX% compound annual growth rate (CAGR). The expected growth during this forecast period is due to the strong backing from healthcare providers, increasing demand for subcutaneous injections, a heightened awareness of multiple sclerosis (MS) and the various treatment options, a rise in multiple sclerosis (MS) cases, and the greenlighting of new indications. Significant trends for this forecast period include advancements in treating multiple sclerosis (MS), a broader reach into emerging markets, a transition towards self-administration, regulatory validations and extensions, and a shift in focus towards personalized medicine.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20126&type=smp
What are the emerging trends shaping the future of the kesimpta market?
The significant trend in the Kesimpta market revolves around the use of self-administered, targeted B-cell therapy for addressing relapsing forms of multiple sclerosis (RMS). Kesimpta offers an effective and convenient method of treatments for RMS, reducing relapses and decelerating the progression of the disease. For example, in April 2024, the Swiss pharmaceutical company Novartis AG released six-year efficiency data for Kesimpta (ofatumumab), its treatment for multiple sclerosis. The benefits were notably significant for recently diagnosed, treatment-naïve individuals with relapsing multiple sclerosis (RMS). The data, derived from the ALITHIOS open-label extension study, highlights the significance of early intervention in managing this chronic condition.
Which growth-oriented segments of the kesimpta market are leading the industry's development?
The kesimpta market covered in this report is segmented -
1) By Indication: Treatment Of Rhabdomyosarcoma (RMS), Treatment Of Clinically Isolated Syndrome (CIS), Treatment Of Active Secondary Progressive Multiple Sclerosis (SPMS)
2) By Formulation: Injectable formulation, Pre-filled Syringes Or Autoinjectors
3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients
4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Specialty Pharmacies, Home Healthcare Providers, Neurology Clinics
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20126
What regions are leading the charge in the kesimpta market?
North America was the largest region in the kesimpta market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kesimpta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What companies are at the forefront of innovation in the kesimpta market?
Major companies operating in the kesimpta market include Novartis AG
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20126&type=smp
What Is Covered In The Kesimpta Global Market Report?
•Market Size Forecast: Examine the kesimpta market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the kesimpta market for a structured understanding.
•Key Players Overview: Analyze major players in the kesimpta market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the kesimpta market.
•Segment Contributions: Evaluate how different segments drive overall growth in the kesimpta market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the kesimpta market.
•Industry Challenges: Identify potential risks and obstacles affecting the kesimpta market.
•Competitive Landscape: Review strategic developments in the kesimpta market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trend Reshaping the Kesimpta Market in 2025: Kesimpta's Impact On Relapsing Multiple Sclerosis (RMS) here
News-ID: 3938110 • Views: …
More Releases from The Business Research Company
Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billio …
"Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Dermal Regeneration Market Size Forecast for 2025?
In recent years, the market size of dermal regeneration has significantly expanded. Its growth is set to continue, moving from a market value of $1.64 billion in 2024, surging to $1.79 billion in 2025, indicating a Compound Annual Growth Rate…
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Dental Emergency Kit Market from 2024 to 2025?
In recent times, the dental emergency kit market has seen significant growth. Projected growth rates suggest an increase from $1.18 billion in 2024 to $1.28 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.2%.…
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billio …
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Cryopreservation Equipment Market Size 2025?
The expansion of the cryopreservation equipment market has been significant in recent years. The market which is expected to escalate from $9.52 billion in 2024 to $11.01 billion in 2025, will do so with a compound annual growth rate…
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Connected Wearable Patches Market Grow by 2025 in Terms of Size and Growth?
The market size for connected wearable patches has seen significant expansion in the most recent years. With an expected rise from $5.62 billion in 2024 to $6.42 billion in 2025, representing a compound annual growth rate…
More Releases for Kesimpta
Impact Of Increasing Multiple Sclerosis Prevalence On The Growth Of The Kesimpta …
The Kesimpta Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Kesimpta Market Size During the Forecast Period?
The market size for kesimpta has seen a XX (HCAGR) spike in recent years. From $XX million in 2024, it's projected to escalate to $XX…
Leading Element Driving Change in the Kesimpta Market in 2025: Impact Of Increas …
What Is the Estimated Market Size and Growth Rate for the Kesimpta Market?
In the past few years, the kesimpta market size has shown an $XX. Predictions indicate growth from $XX million in 2024 to $XX million in 2025, marking a compound annual growth rate (CAGR) of $XX%. The notable development during the historical timeframe is a result of broader access to healthcare, progress in biological therapies, rising occurrence of multiple…
Neurology Clinical Trials for Huntington's disease to Register 6% CAGR during th …
The global neurology clinical trials market was valued at US$ 5.4 Bn in 2021 and is expected to reach US$ 10.5 Bn by 2032 finds Future Market Insights (FMI) in a recent market survey. As per the findings, the neurology clinical trials market for Huntington's disease achieved a growth rate of 5.2% during 2017-2021. Huntington's disease occurs in every 2.7 per 100,000 habitats worldwide. Egypt contributes to the highest number…
Multiple Sclerosis Treatment Market Growth, Sales Revenue, Competitive Landscape …
Market overview:
The multiple sclerosis treatment market is expected to grow USD 28.09 billion at a compound annual growth rate of 2.80%. During the forecast period 2022-2030
Multiple sclerosis symptoms include neuropathy or weakness of the limbs, electric shocks with neck movements, double vision, tremors, bowel and bladder problems, and unsteady gait. Clinical research and R&D investments are generating much interest in the market for multiple sclerosis treatments. Many pharmaceutical companies are…
Global Multiple Sclerosis Drugs Market Trends, Business Overview, Industry Growt …
The Global Multiple Sclerosis Drugs Market is anticipated to grow at a CAGR of nearly 6.1% during the forecast period (2022-2028). Multiple sclerosis is defined as an immune-mediated disease of the central nervous system. It is characterized by demyelination, inflammation, and degenerative changes such as progressive brain and spinal cord atrophy, neuroaxonal loss, and others. The major factor attributed to the market growth includes the rising prevalence of multiple sclerosis.…
Global Multiple Sclerosis Drugs Market By Size, Demand Analysis, Type, Statistic …
The Global Multiple Sclerosis Drugs Market is anticipated to grow at a CAGR of nearly 6.1% during the forecast period (2022-2028). Multiple sclerosis is defined as an immune-mediated disease of the central nervous system. It is characterized by demyelination, inflammation, and degenerative changes such as progressive brain and spinal cord atrophy, neuroaxonal loss, and others. The major factor attributed to the market growth includes the rising prevalence of multiple sclerosis.…
